Back
Arrowhead Pharmaceuticals Vs. Janux Therapeutics Industry Stock Comparison
Sell
22
ARWR
Arrowhead Pharmaceuticals
Last Price:
$19.75
Seasonality Move:
30.56%
Sell
23
JANX
Janux Therapeutics
Last Price:
$50.53
Seasonality Move:
80.32%
Sell
22
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals [ARWR] share price is $19.75. The Score for ARWR is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
-
The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals's stock price today?
-
The Arrowhead Pharmaceuticals share price today is $19.75Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight selling pressure.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $50.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
ARWR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.59 | Sell |
Relative Strength Index (14 RSI): | 44.89 | Sell |
Chaikin Money Flow: | -701172 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.11 - 23.01) | Sell |
Bollinger Bands (100): | (18.92 - 23.1) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -1994706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.74 - 62.68) | Sell |
Bollinger Bands (100): | (44.76 - 56.7) | Buy |
ARWR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.34 | Buy |
20-day SMA: | 20.41 | Sell |
50-day SMA: | 20.94 | Sell |
200-day SMA: | 23.2 | Sell |
8-day EMA: | 19.63 | Buy |
20-day EMA: | 20.2 | Sell |
50-day EMA: | 20.78 | Sell |
200-day EMA: | 23.32 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.68 | Sell |
20-day SMA: | 56.78 | Sell |
50-day SMA: | 54.64 | Sell |
200-day SMA: | 47.7 | Buy |
8-day EMA: | 54.12 | Sell |
20-day EMA: | 55.17 | Sell |
50-day EMA: | 54.12 | Sell |
200-day EMA: | 45.19 | Buy |
Arrowhead Pharmaceuticals Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.16 per share, and a decrease next year of $0.58 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.
Arrowhead Pharmaceuticals Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |